Oscar Health (OSCR) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $33.47, -2.48% vs the prior close of $34.32.
- Volume 5.10M shares, 0.9x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
OSCR dips 2.5% to $33.47. Closed at $33.47, -2.48% vs the prior close of $34.32. Day range $32.65–$33.90, opened at $33.75.
OSCR daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — OSCR dips 2.5% to $33.47
- Closed at $33.47, -2.48% vs the prior close of $34.32. Day range $32.65–$33.90, opened at $33.75.
- Volume was 5.10M shares, 0.9x its 50-day average of 5.61M.
- Price is +6.9% vs its 50-day average ($31.31) and +47.1% vs its 200-day average ($22.75).
- 52-week range $10.69–$35.01; today's close sits at 94% of that range, 4.4% below the 52-week high.
Oct 14, 2026 — OSCR rises 1.6% to $34.32, a 52-week high
- Closed at $34.32, +1.57% vs the prior close of $33.79. Day range $33.21–$34.53, opened at $33.67.
- Volume was 5.28M shares, 0.9x its 50-day average of 5.57M.
- Price is +9.8% vs its 50-day average ($31.25) and +51.5% vs its 200-day average ($22.66).
- 52-week range $10.69–$35.01; today's close sits at 97% of that range, 2.0% below the 52-week high.
Oct 13, 2026 — OSCR dips 0.6% to $33.79
- Closed at $33.79, -0.65% vs the prior close of $34.01. Day range $33.35–$35.01, opened at $34.50.
- Volume was 5.47M shares, 1.0x its 50-day average of 5.53M.
- Price is +8.4% vs its 50-day average ($31.17) and +49.8% vs its 200-day average ($22.56).
- 52-week range $10.69–$35.01; today's close sits at 95% of that range, 3.5% below the 52-week high.
Oct 12, 2026 — OSCR rises 1.9% to $34.01, a 52-week high, 4 up days in a row
- Closed at $34.01, +1.92% vs the prior close of $33.37. Day range $33.23–$34.40, opened at $33.70.
- Volume was 5.78M shares, 1.1x its 50-day average of 5.48M.
- Price is +9.3% vs its 50-day average ($31.11) and +51.4% vs its 200-day average ($22.46).
- 52-week range $10.69–$34.48; today's close sits at 98% of that range, 1.4% below the 52-week high.
- That makes 4 straight gains.
Oct 9, 2026 — OSCR rises 0.8% to $33.37, 3 up days in a row
- Closed at $33.37, +0.82% vs the prior close of $33.10. Day range $32.69–$34.14, opened at $33.16.
- Volume was 5.32M shares, 1.0x its 50-day average of 5.45M.
- Price is +7.5% vs its 50-day average ($31.05) and +49.2% vs its 200-day average ($22.37).
- 52-week range $10.69–$34.48; today's close sits at 95% of that range, 3.2% below the 52-week high.
- That makes 3 straight gains.
Oct 8, 2026 — OSCR rises 0.6% to $33.10
- Closed at $33.10, +0.58% vs the prior close of $32.91. Day range $32.25–$33.42, opened at $32.75.
- Volume was 4.13M shares, 0.8x its 50-day average of 5.48M.
- Price is +6.7% vs its 50-day average ($31.01) and +48.6% vs its 200-day average ($22.28).
- 52-week range $10.69–$34.48; today's close sits at 94% of that range, 4.0% below the 52-week high.
Oct 7, 2026 — OSCR rises 1.8% to $32.91
- Closed at $32.91, +1.76% vs the prior close of $32.34. Day range $31.80–$33.51, opened at $32.03.
- Volume was 5.43M shares, 1.0x its 50-day average of 5.52M.
- Price is +6.3% vs its 50-day average ($30.96) and +48.3% vs its 200-day average ($22.19).
- 52-week range $10.69–$34.48; today's close sits at 93% of that range, 4.6% below the 52-week high.
Oct 6, 2026 — OSCR ends flat (-0.2%) to $32.34
- Closed at $32.34, -0.25% vs the prior close of $32.42. Day range $32.02–$32.84, opened at $32.53.
- Volume was 4.89M shares, 0.9x its 50-day average of 5.49M.
- Price is +4.6% vs its 50-day average ($30.93) and +46.4% vs its 200-day average ($22.10).
- 52-week range $10.69–$34.48; today's close sits at 91% of that range, 6.2% below the 52-week high.
Oct 5, 2026 — OSCR jumps 4.8% to $32.42
- Closed at $32.42, +4.78% vs the prior close of $30.94. Day range $30.84–$32.67, opened at $30.97.
- Volume was 4.68M shares, 0.9x its 50-day average of 5.47M.
- Price is +5.1% vs its 50-day average ($30.85) and +47.3% vs its 200-day average ($22.01).
- 52-week range $10.69–$34.48; today's close sits at 91% of that range, 6.0% below the 52-week high.
Oct 2, 2026 — OSCR jumps 3.5% to $30.94
- Closed at $30.94, +3.48% vs the prior close of $29.90. Day range $29.69–$31.17, opened at $29.82.
- Volume was 3.90M shares, 0.7x its 50-day average of 5.48M.
- Price is +0.6% vs its 50-day average ($30.76) and +41.1% vs its 200-day average ($21.93).
- 52-week range $10.69–$34.48; today's close sits at 85% of that range, 10.3% below the 52-week high.
OSCR latest news & SEC filings
Every SEC filing by or about OSCR in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 13, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 13, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 13, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 22, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Wittman Vanessa Ames sold 25,000 shares at $32.24 (≈$806.00K) on Sep 18, 2026; now holds 112,121
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 18, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Kushner Joshua reported an other transaction of 6,268,097 shares on Sep 18, 2026
- Kushner Joshua reported an other transaction of 75,520 shares on Sep 18, 2026
- Kushner Joshua reported an other transaction of 1,323,589 shares on Sep 18, 2026; now holds 1,323,589
- Kushner Joshua reported an other transaction of 4,855,810 shares on Sep 18, 2026; now holds 4,855,810
- Kushner Joshua reported an other transaction of 164,218 shares on Sep 18, 2026; now holds 164,218
- Kushner Joshua reported an other transaction of 1,323,589 shares on Sep 18, 2026
- …plus 2 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 18, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Thrive Partners Ii Gp, Llc & Thrive Capital Partners Ii, L.P. & Thrive Partners Iii Gp, Llc & Thrive Capital Partners Iii, L.P. & Claremount Tw, L.P. & Thrive Partners Vii Growth Gp, Llc & Thrive Capital Partners Vii Growth, L.P. & Thrive Partners Vii Gp, Llc & Claremount Vii Associates, L.P. reported an other transaction of 6,268,097 shares on Sep 18, 2026
- Thrive Partners Ii Gp, Llc & Thrive Capital Partners Ii, L.P. & Thrive Partners Iii Gp, Llc & Thrive Capital Partners Iii, L.P. & Claremount Tw, L.P. & Thrive Partners Vii Growth Gp, Llc & Thrive Capital Partners Vii Growth, L.P. & Thrive Partners Vii Gp, Llc & Claremount Vii Associates, L.P. reported an other transaction of 75,520 shares on Sep 18, 2026
- Thrive Partners Ii Gp, Llc & Thrive Capital Partners Ii, L.P. & Thrive Partners Iii Gp, Llc & Thrive Capital Partners Iii, L.P. & Claremount Tw, L.P. & Thrive Partners Vii Growth Gp, Llc & Thrive Capital Partners Vii Growth, L.P. & Thrive Partners Vii Gp, Llc & Claremount Vii Associates, L.P. reported an other transaction of 1,323,589 shares on Sep 18, 2026; now holds 1,323,589
- Thrive Partners Ii Gp, Llc & Thrive Capital Partners Ii, L.P. & Thrive Partners Iii Gp, Llc & Thrive Capital Partners Iii, L.P. & Claremount Tw, L.P. & Thrive Partners Vii Growth Gp, Llc & Thrive Capital Partners Vii Growth, L.P. & Thrive Partners Vii Gp, Llc & Claremount Vii Associates, L.P. reported an other transaction of 4,855,810 shares on Sep 18, 2026; now holds 4,855,810
- Thrive Partners Ii Gp, Llc & Thrive Capital Partners Ii, L.P. & Thrive Partners Iii Gp, Llc & Thrive Capital Partners Iii, L.P. & Claremount Tw, L.P. & Thrive Partners Vii Growth Gp, Llc & Thrive Capital Partners Vii Growth, L.P. & Thrive Partners Vii Gp, Llc & Claremount Vii Associates, L.P. reported an other transaction of 164,218 shares on Sep 18, 2026; now holds 164,218
- Thrive Partners Ii Gp, Llc & Thrive Capital Partners Ii, L.P. & Thrive Partners Iii Gp, Llc & Thrive Capital Partners Iii, L.P. & Claremount Tw, L.P. & Thrive Partners Vii Growth Gp, Llc & Thrive Capital Partners Vii Growth, L.P. & Thrive Partners Vii Gp, Llc & Claremount Vii Associates, L.P. reported an other transaction of 1,323,589 shares on Sep 18, 2026
- …plus 2 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 18, 2026 · SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 16, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 7, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $6.09M (prior year $6.50M) (-6.2% vs Jun 30, 2025)
- Net income: $361.81M (prior year -$228.36M) (swung to profit vs Jun 30, 2025)
- Diluted EPS: $1.10 (prior year -$0.89) (swung to profit vs Jun 30, 2025)
Aug 6, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Things to know before you trade OSCR
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: May 6, 2026, Feb 10, 2026, Nov 6, 2025. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.95% (largest 5.4%).
- Liquidity: about 5.48M shares (≈$183.26M) trade per day on average.
- 52-week position: $33.47 vs a range of $10.69–$35.01 (94% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Vanessa Ames Wittman sold 25,000 shares on Sep 18, 2026.
- Latest filings: 8-K Sep 16, 2026; 10-Q Aug 7, 2026; 8-K Aug 6, 2026.
- Listing: NYSE · industry: Hospital & Medical Service Plans.
OSCR market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 33.75 | 33.90 | 32.65 | 33.47 | 5.10M |
| Oct 14, 2026 | 33.67 | 34.53 | 33.21 | 34.32 | 5.28M |
| Oct 13, 2026 | 34.50 | 35.01 | 33.35 | 33.79 | 5.47M |
| Oct 12, 2026 | 33.70 | 34.40 | 33.23 | 34.01 | 5.78M |
| Oct 9, 2026 | 33.16 | 34.14 | 32.69 | 33.37 | 5.32M |
| Oct 8, 2026 | 32.75 | 33.42 | 32.25 | 33.10 | 4.13M |
| Oct 7, 2026 | 32.03 | 33.51 | 31.80 | 32.91 | 5.43M |
| Oct 6, 2026 | 32.53 | 32.84 | 32.02 | 32.34 | 4.89M |
| Oct 5, 2026 | 30.97 | 32.67 | 30.84 | 32.42 | 4.68M |
| Oct 2, 2026 | 29.82 | 31.17 | 29.69 | 30.94 | 3.90M |
| Oct 1, 2026 | 30.69 | 31.06 | 29.73 | 29.90 | 3.94M |
| Sep 30, 2026 | 29.75 | 30.99 | 29.52 | 30.84 | 5.45M |
| Sep 29, 2026 | 29.73 | 29.83 | 28.99 | 29.77 | 3.80M |
| Sep 28, 2026 | 29.51 | 30.24 | 29.20 | 29.65 | 4.01M |
| Sep 25, 2026 | 29.02 | 29.98 | 28.80 | 29.60 | 4.90M |
| Sep 24, 2026 | 30.30 | 30.70 | 28.30 | 28.87 | 5.78M |
| Sep 23, 2026 | 30.38 | 30.89 | 29.80 | 30.53 | 5.52M |
| Sep 22, 2026 | 31.47 | 31.48 | 29.22 | 30.67 | 8.24M |
| Sep 21, 2026 | 31.00 | 32.16 | 30.37 | 31.29 | 8.43M |
| Sep 18, 2026 | 32.24 | 33.18 | 31.28 | 32.13 | 9.45M |
About Oscar Health
Oscar Health (OSCR) is listed on the NYSE and classified by the SEC under “Hospital & Medical Service Plans”. Its business address is in NEW YORK, NY. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1568651.
OSCR board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Jeffery H Boyd | Director | Apr 13, 2026 |
| Mark T Bertolini | Chief Executive Officer | Jul 1, 2026 |
| Tw, L.P. Claremount | Director | Sep 18, 2026 |
| Vii Associates, L.P. Claremount | Director | Sep 18, 2026 |
| William Gassen | Director | Jul 13, 2026 |
| Joshua Kushner | Co-Founder and Vice Chairman | Sep 18, 2026 |
| Laura W Lang | Director | Jun 8, 2026 |
| David Plouffe | Director | Jul 13, 2026 |
| Sid Sankaran | Director | Jul 13, 2026 |
| Mario Schlosser | Director | Sep 8, 2026 |
| Capital Partners Ii, L.P. Thrive | Director | Sep 18, 2026 |
| Capital Partners Iii, L.P. Thrive | Director | Sep 18, 2026 |
| Capital Partners Vii Growth, L.P. Thrive | Director | Sep 18, 2026 |
| Partners Ii Gp, Llc Thrive | Director | Sep 18, 2026 |
| Partners Iii Gp, Llc Thrive | Director | Sep 18, 2026 |
| Partners Vii Gp, Llc Thrive | Director | Sep 18, 2026 |
| Partners Vii Growth Gp, Llc Thrive | Director | Sep 18, 2026 |
| Vanessa Ames Wittman | Director | Sep 22, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Victoria Baltrus | Chief Accounting Officer | Sep 8, 2026 |
| Mark T Bertolini | Chief Executive Officer | Jul 1, 2026 |
| Richard Scott Blackley | Chief Financial Officer | Sep 8, 2026 |
| Joshua Kushner | Co-Founder and Vice Chairman | Sep 18, 2026 |
| Janet Liang | President, Oscar Insurance | Sep 8, 2026 |
| Adam Mcananey | Chief Legal Officer | Sep 8, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 18, 2026 | Vanessa Ames Wittman | Sale | 25,000 | $32.24 |
| Sep 3, 2026 | Victoria Baltrus | Sale | 958 | $31.45 |
| Sep 3, 2026 | Richard Scott Blackley | Sale | 28,869 | $31.45 |
| Sep 3, 2026 | Janet Liang | Sale | 10,360 | $31.45 |
| Sep 3, 2026 | Mario Schlosser | Sale | 31,422 | $31.45 |
| Sep 3, 2026 | Adam Mcananey | Sale | 9,092 | $31.45 |
| Aug 28, 2026 | Mario Schlosser | Sale | 150,000 | $30.79 |
| Aug 27, 2026 | Mario Schlosser | Sale | 600,000 | $30.34 |
| Aug 18, 2026 | Richard Scott Blackley | Sale | 18,750 | $31.74 |
| Jul 1, 2026 | Mario Schlosser | Sale | 3,600 | $29.50 |
| Jul 1, 2026 | Mario Schlosser | Sale | 13,672 | $30.80 |
| Jul 1, 2026 | Mario Schlosser | Sale | 30,228 | $31.65 |
| Jun 30, 2026 | Mark T Bertolini | Sale | 488,654 | $28.35 |
| Jun 30, 2026 | Mark T Bertolini | Sale | 135,590 | $28.97 |
| Jun 29, 2026 | Mark T Bertolini | Sale | 58,926 | $30.08 |
OSCR financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $28.59M | $-443.15M | -1.69 | $1.09B |
| Dec 31, 2024 | $20.58M | $25.43M | 0.10 | $978.19M |
| Dec 31, 2023 | $21.35M | $-270.73M | -1.22 | $-272.16M |
| Dec 31, 2022 | $64.93M | $-606.27M | -2.85 | $380.35M |
| Dec 31, 2021 | $5.39M | $-572.61M | -3.20 | $-181.75M |
Latest balance sheet: total assets $11.23B, total liabilities $9.17B, cash $4.08B (as of Jun 30, 2026).
OSCR earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $26.54 |
| May 6, 2026 | 8-K Item 2.02 (results) | $19.84 |
| Feb 10, 2026 | 8-K Item 2.02 (results) | $12.88 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $16.56 |
| Aug 6, 2025 | 8-K Item 2.02 (results) | $14.34 |
| Jul 22, 2025 | 8-K Item 2.02 (results) | $14.70 |
| May 7, 2025 | 8-K Item 2.02 (results) | $17.02 |
| Feb 4, 2025 | 8-K Item 2.02 (results) | $15.28 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $13.64 |
| Aug 7, 2024 | 8-K Item 2.02 (results) | — |
| May 7, 2024 | 8-K Item 2.02 (results) | — |
| Feb 7, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Hospital & Medical Service Plans
UnitedHealth (UNH)Elevance Health (ELV)Cigna (CI)Humana (HUM)Centene (CNC)Molina Healthcare (MOH)Alignment Healthcare (ALHC)Clover Health Investments (CLOV)Trupanion (TRUP)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on OSCR
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.